Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHT, a testosterone byproduct, causes male pattern baldness.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Suppressing certain hormones might help prevent prostate cancer.

PRP injections effectively promote hair growth in androgenetic alopecia patients.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Various treatments exist for hair loss, but more research is needed for better options.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Experts created guidelines for treating hair loss in Egypt, focusing on personalized care.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.